News


Uniting Strength in Chengdu, Capping a Successful Run | Jinlangbo Pharmaceutical Makes a Splendid Debut at the 23rd China Animal Husbandry Expo


From May 18 to 20, the 23rd China Animal Husbandry Expo and the 2026 China International Animal Husbandry Expo were grandly held at the China Western International Expo City in Chengdu. With the theme “Showcasing New Business Models, Sharing New Achievements, Boosting New Momentum, and Leading New Development,” this year’s expo spanned over 190,000 square meters, bringing together more than 1,500 domestic and international enterprises from 55 countries and regions to jointly explore new pathways for high-quality development in the animal husbandry sector.

As a high-tech enterprise under the Jingxin Group specializing in animal nutrition and health, Jinlangbo Pharmaceutical leverages its expertise to drive industry innovation, making a striking appearance at Booth 0175 in Hall No. 1 and becoming one of the event’s standout highlights.

During the exhibition, our technical team and key sales representatives warmly welcomed every visiting customer and partner. From discussions on cutting-edge industry technologies to in-depth analyses of real‑world farming challenges, and through detailed negotiations on specific collaboration plans, the on‑site exchanges were both lively and pragmatic. Focusing on industry needs, Jinlangbo Pharmaceutical showcased its flagship product, 25‑hydroxyvitamin D3, addressing core applications such as livestock and poultry nutrition, skeletal health, and enhanced production performance. With its outstanding advantages—high bioavailability, superior improvement of eggshell quality, increased laying rates, and promotion of bone development—this product became a major highlight of the event, with numerous customers expressing strong interest in establishing in‑depth partnerships right on the spot.

This livestock expo is not merely a showcase of products; it also serves as a platform for industry dialogue, resource networking, and renewed confidence. Moving forward, Jinlangbo Pharmaceutical will continue to ramp up investment in technological innovation, refine its product portfolio, and elevate its professional services, delivering higher‑quality offerings and more efficient solutions. Together with our colleagues across the livestock sector, we will forge ahead and jointly drive the industry’s high‑quality development.